Medical Properties Trust (0JZZ) Ratios
Medical Properties Trust Ratios
GB:0JZZ's free cash flow for Q2 2026 was $62.44M. For the 2026 fiscal year, GB:0JZZ's free cash flow was increased by $0.00 and operating cash flow was $62.44M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.51 | 1.55 | 2.52 | 2.18 | 4.06 |
| Quick Ratio | 1.51 | 1.55 | 2.52 | 2.65 | 2.10 |
| Cash Ratio | 0.45 | 0.39 | 0.45 | 0.36 | 0.73 |
| Solvency Ratio | -0.00 | -0.21 | 0.00 | 0.13 | 0.10 |
| Operating Cash Flow Ratio | 0.19 | 0.29 | 0.91 | 1.14 | 1.28 |
| Short-Term Operating Cash Flow Coverage | 0.36 | 0.68 | 1.09 | 1.53 | 193.25 |
| Net Current Asset Value | $ -8.58B | $ -8.15B | $ -9.27B | $ -9.34B | $ -7.52B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.65 | 0.63 | 0.56 | 0.58 | 0.56 |
| Debt-to-Equity Ratio | 2.13 | 1.86 | 1.34 | 1.32 | 1.36 |
| Debt-to-Capital Ratio | 0.68 | 0.65 | 0.57 | 0.57 | 0.58 |
| Long-Term Debt-to-Capital Ratio | 0.66 | 0.64 | 0.56 | 0.53 | 0.57 |
| Financial Leverage Ratio | 3.26 | 2.96 | 2.40 | 2.29 | 2.43 |
| Debt Service Coverage Ratio | 0.44 | -1.96 | 1.76 | 2.65 | 306.19 |
| Interest Coverage Ratio | 1.06 | 0.92 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 3.23 | 3.73 | 3.43 | 1.54 | 0.81 |
| Interest Debt Per Share | 17.20 | 15.66 | 17.08 | 18.95 | 19.43 |
| Net Debt to EBITDA | 17.01 | -5.81 | 14.30 | 7.54 | 7.95 |
| Profitability Margins | |||||
| Gross Profit Margin | 96.25% | 97.26% | 95.23% | 97.04% | 97.47% |
| EBIT Margin | 28.09% | -195.08% | 9.32% | 65.05% | 67.24% |
| EBITDA Margin | 56.16% | -149.50% | 78.53% | 86.64% | 88.04% |
| Operating Profit Margin | 55.53% | 38.86% | 9.32% | 65.05% | 67.24% |
| Pretax Profit Margin | -24.41% | -237.48% | -78.78% | 62.20% | 47.32% |
| Net Profit Margin | -28.50% | -242.11% | -63.83% | 58.50% | 42.47% |
| Continuous Operations Profit Margin | -28.39% | -241.91% | -63.79% | 58.58% | 42.53% |
| Net Income Per EBT | 116.74% | 101.95% | 81.03% | 94.05% | 89.76% |
| EBT Per EBIT | -43.97% | -611.14% | -844.90% | 95.62% | 70.37% |
| Return on Assets (ROA) | -1.85% | -16.86% | -3.04% | 4.59% | 3.20% |
| Return on Equity (ROE) | -6.01% | -49.87% | -7.29% | 10.50% | 7.77% |
| Return on Capital Employed (ROCE) | 3.91% | 2.88% | 0.50% | 5.55% | 5.22% |
| Return on Invested Capital (ROIC) | 3.74% | 2.80% | 0.37% | 4.97% | 4.69% |
| Return on Tangible Assets | -1.96% | -16.86% | -3.04% | 4.59% | 3.41% |
| Earnings Yield | -9.22% | -101.65% | -18.94% | 13.53% | 4.71% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.89 | 1.18 | 1.28 | 1.31 | 0.73 |
| Payables Turnover | 0.00 | 0.00 | 0.10 | 0.07 | 0.06 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -0.15 | 0.03 |
| Fixed Asset Turnover | 0.00 | 0.00 | 2.91 | 0.11 | 7.68 |
| Asset Turnover | 0.06 | 0.07 | 0.05 | 0.08 | 0.08 |
| Working Capital Turnover Ratio | 1.80 | -20.14 | 1.08 | 1.14 | 0.91 |
| Cash Conversion Cycle | 408.16 | 310.28 | 407.65 | 279.64 | -4964.21 |
| Days of Sales Outstanding | 408.16 | 310.28 | 407.65 | 279.64 | 670.63 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 5634.84 |
| Operating Cycle | 408.16 | 310.28 | 407.65 | 279.64 | 670.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.38 | 0.41 | 0.85 | 1.23 | 1.38 |
| Free Cash Flow Per Share | 0.38 | 0.41 | 0.85 | -1.34 | 1.27 |
| Dividend Paid and CapEx Coverage Ratio | 1.19 | 0.76 | 0.82 | 0.33 | 1.14 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.48 | 12.38 |
| Operating Cash Flow Coverage Ratio | 0.02 | 0.03 | 0.05 | 0.07 | 0.07 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.25 | 0.58 | 0.48 | 0.53 |
| Free Cash Flow Yield | 7.68% | 10.35% | 17.21% | -12.02% | 5.36% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -10.87 | -0.98 | -5.28 | 7.39 | 21.21 |
| Price-to-Sales (P/S) Ratio | 3.09 | 2.38 | 3.37 | 4.32 | 9.01 |
| Price-to-Book (P/B) Ratio | 0.65 | 0.49 | 0.39 | 0.78 | 1.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.02 | 9.66 | 5.81 | -8.32 | 18.65 |
| Price-to-Operating Cash Flow Ratio | 13.02 | 9.66 | 5.81 | 9.02 | 17.14 |
| Price-to-Earnings Growth (PEG) Ratio | 0.12 | -0.00 | 0.03 | 0.21 | 0.57 |
| Enterprise Value Multiple | 22.51 | -7.40 | 18.86 | 13.30 | 18.31 |
| Enterprise Value | 12.29B | 11.02B | 12.91B | 16.85B | 24.83B |
| EV to EBITDA | 22.51 | -7.40 | 18.51 | 12.49 | 18.09 |
| EV to Sales | 12.64 | 11.07 | 14.81 | 10.92 | 16.07 |
| EV to Free Cash Flow | 53.26 | 44.88 | 25.52 | -21.02 | 33.28 |
| EV to Operating Cash Flow | 53.26 | 44.88 | 25.52 | 22.80 | 30.59 |
| Tangible Book Value Per Share | 6.22 | 8.05 | 11.03 | -8.80 | 11.94 |
| Shareholders’ Equity Per Share | 7.67 | 8.05 | 12.75 | 14.35 | 14.33 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.16 | -0.02 | 0.19 | 0.06 | 0.10 |
| Revenue Per Share | 1.62 | 1.66 | 1.46 | 2.58 | 2.62 |
| Net Income Per Share | -0.46 | -4.02 | -0.93 | 1.51 | 1.11 |
| Tax Burden | 1.17 | 1.02 | 0.81 | 0.94 | 0.90 |
| Interest Burden | -0.87 | 1.22 | -8.45 | 0.96 | 0.70 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.13 | 0.17 | 0.10 | 0.09 |
| Stock-Based Compensation to Revenue | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 |
| Income Quality | -0.84 | -0.10 | -0.91 | 0.82 | 1.24 |
Currency in USD
